Case Report: Diagnosis and treatment analysis of a case of primary pulmonary sarcoma
Frontiers in Cardiovascular Medicine · 2026-11-12 · 13
DOI: 10.3389/fcvm.2026.1796747 ↗Abstract
Objective This study aimed to explore the clinical features, diagnostic points, and treatment strategies of primary pulmonary artery sarcoma (PPAS) and improve the understanding of this rare disease. Methods A retrospective analysis of the clinical data of a PPAS patient admitted to our hospital in December 2021 was conducted. The clinical manifestations, imaging features, pathological diagnosis, and treatment process were systematically summarized, followed by a discussion based on the literature. Results The patient was a 39-year-old female who presented with dry cough and fatigue, and gradually developed hemoptysis, chest pain, and difficulty breathing. Multimodal imaging examination revealed a mass in the upper lobe of the left lung with extensive pulmonary embolism, and PET/CT suggested increased glucose metabolism at the site of pulmonary embolism. The postoperative pathological diagnosis was polymorphic undifferentiated sarcoma, and immunohistochemistry exhibited high expression of Ki-67 (60%). Genetic testing revealed TP53 mutations and increased CDK4 copy number. The patient underwent surgical resection combined with targeted therapy and radiotherapy. Follow-up indicated tumor reduction, symptom relief, and survival exceeding 14 months. Conclusion The clinical manifestations of PPAS lack specificity and are easily misdiagnosed as pulmonary thromboembolism. Multimodal imaging evaluation, timely histopathological examination, and individualized comprehensive treatment are crucial for improving prognosis.
EUVIMED